Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali Ҷилди 8 № 3 (2023)
CHANGES IN THE LEVEL OF C-REACTIVE PROTEIN IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION WHILE TAKING COLCHICINE
АГАБАБЯН Ирина Рубеновна, КОБИЛОВА Нигина Акмаловна
Аннотатсия
Purpose: To study the effect of colchicine on the level of C-reactive protein in patients undergoing percutaneous coronary intervention (PCI). Materials and methods: We conducted an analysis with coronary heart disease, who underwent myocardial infarction, underwent PCI from August 1 to November 1, 2022 according to the Samarkand regional regional branch of the Republican Specialized Scientific and Practical Medical Center for Cardiology. A total of 52 patients were analyzed, who underwent interventional intervention (PCI), stenting of the coronary arteries with radial access. Conclusion: The use of colchicine at a dose of 0.5 mg per day for 3 months after PCI significantly reduced the level of C-reactive protein, and in the group without colchicine, CRP remained practically at the same positions.
Колхицин, C-реактивный белок, чрескожное коронарное вмешательство (ЧКВ), атеросклероз, ИБСColchicine, C-reactive protein, percutaneous coronary admixture (PCI), atherosclerosis, CADKolxitsin, C-reaktiv oqsil, teri orqali koronar aralashuv (TKA), ateroskleroz, yurak ishemik kasalligi
Манбаи метамаълумот: бойгонии OAI-PMH-и маҷалла · Sindex матни пурраро нигоҳ намедорад, ба манбаъ пайванд медиҳад.